Nephrology & Pharmacology
Creatinine Clearance (Cockcroft-Gault Formula): Complete Clinical Guide for Doctors and Medical Students
By Dr. S. Biswas, MBBS MD Medicine · March 2026 · 9 min read
- What Is Creatinine Clearance?
- Cockcroft-Gault: Step-by-Step Worked Example
- Calculate Creatinine Clearance Instantly
- Creatinine Clearance vs eGFR: Which One to Use?
- CKD Staging by Creatinine Clearance / eGFR
- Drug Dosing in Renal Impairment: Key Examples
- Limitations of the Cockcroft-Gault Formula
- 1. Not validated in AKI
- 2. Inaccurate at extremes of muscle mass
- 3. Pregnancy
- 4. Oedematous patients
- A Note for Patients
- Summary
- References
- Explore All AI Medical Tools
You have a patient with chronic kidney disease. You need to prescribe metformin, gentamicin, enoxaparin, or digoxin. The dose depends on renal function — but which renal function number do you use? eGFR from the lab report, or creatinine clearance you calculate yourself?
This is one of the most practically important questions in day-to-day clinical medicine, and the answer is not always obvious. Getting it wrong means either underdosing and treatment failure, or overdosing and drug toxicity — both of which cause real patient harm.
This guide explains exactly what creatinine clearance is, how to calculate it using the Cockcroft-Gault formula, when to use it over eGFR, and which drugs require dose adjustment at which levels of renal function.
What Is Creatinine Clearance?
Creatinine clearance (CrCl) is an estimate of the glomerular filtration rate (GFR) — the volume of blood the kidneys filter per minute. It is calculated from the serum creatinine level along with the patient’s age, weight, and sex, using the Cockcroft-Gault formula.
Creatinine is a waste product of muscle metabolism. It is filtered freely at the glomerulus and secreted in small amounts by the tubules. Because its production is relatively constant, the rate at which it is cleared from the blood reflects how well the kidneys are filtering.
Cockcroft-Gault Formula
CrCl (mL/min) = [(140 − Age) × Weight × F] ÷ Serum Creatinine
Age in years · Weight in kg · Serum creatinine in µmol/L
F = 1.23 for males · F = 1.04 for females
The result is expressed in mL/min and represents the estimated volume of plasma cleared of creatinine per minute. A normal CrCl is approximately 90–120 mL/min in a healthy adult, though this declines naturally with age.
Cockcroft-Gault: Step-by-Step Worked Example
A 72-year-old male. Weight 68 kg. Serum creatinine 180 µmol/L. Calculate his creatinine clearance.
- 140 − 72 = 68
- 68 × 68 (weight) = 4,624
- 4,624 × 1.23 (male factor) = 5,687.5
- 5,687.5 ÷ 180 (creatinine) = 31.6 mL/min
CrCl = 31.6 mL/min → Severe renal impairment (Stage 3b–4)
Significant dose adjustments required for many drugs · Avoid nephrotoxic agents · Review all medications
Calculate Creatinine Clearance Instantly
Enter age, weight, sex, and serum creatinine — get CrCl with renal stage classification and drug dosing guidance in seconds.
Creatinine Clearance vs eGFR: Which One to Use?
This is where most confusion lies. The lab reports an eGFR (estimated GFR, calculated using the CKD-EPI or MDRD equation). The pharmacist and BNF reference CrCl from Cockcroft-Gault. They are not the same number — and for drug dosing, the distinction matters.
| Feature | eGFR (CKD-EPI/MDRD) | CrCl (Cockcroft-Gault) |
|---|---|---|
| Reported as | mL/min/1.73m² (normalised to BSA) | mL/min (absolute) |
| Use for | CKD staging, disease monitoring | Drug dosing, renal dose adjustment |
| Incorporates weight? | No | Yes |
| Better in extremes of weight? | No | Yes (with IBW adjustment) |
| Drug trials validated with | Rarely | Yes — most RCTs used Cockcroft-Gault |
CKD Staging by Creatinine Clearance / eGFR
| CKD Stage | GFR (mL/min/1.73m²) | Description |
|---|---|---|
| G1 | ≥90 | Normal or high (with other markers of kidney damage) |
| G2 | 60–89 | Mildly decreased |
| G3a | 45–59 | Mild-to-moderate decrease |
| G3b | 30–44 | Moderate-to-severe decrease |
| G4 | 15–29 | Severely decreased — nephrology referral |
| G5 | <15 | Kidney failure — RRT consideration |
Drug Dosing in Renal Impairment: Key Examples
The following table covers the most commonly encountered drugs requiring dose adjustment. Always cross-check with the current BNF and local formulary before prescribing.
| Drug | CrCl Threshold | Action Required |
|---|---|---|
| Metformin | 30–45 mL/min | Reduce dose, review regularly. Stop if <30. |
| Enoxaparin (LMWH) | <30 mL/min | Switch to unfractionated heparin or reduce dose with anti-Xa monitoring. |
| Digoxin | <60 mL/min | Reduce dose. Monitor levels. High toxicity risk. |
| Gentamicin | Any impairment | Adjust dosing interval. Monitor trough levels. Avoid if possible in CKD 4–5. |
| Apixaban | <25 mL/min | Avoid (limited evidence). Use with caution 25–50 with dose reduction criteria. |
| Rivaroxaban | <15 mL/min | Avoid. Caution and dose reduction at 15–50 mL/min depending on indication. |
| Trimethoprim | <30 mL/min | Halve dose. Avoid prolonged courses. Monitor potassium and creatinine. |
| NSAIDs | <60 mL/min | Avoid if possible — cause afferent arteriolar constriction and worsen renal function acutely. |
| Spironolactone | <30 mL/min | Avoid — significant hyperkalaemia risk, especially with ACEi/ARB. |
Limitations of the Cockcroft-Gault Formula
1. Not validated in AKI
Cockcroft-Gault assumes a steady-state creatinine. In acute kidney injury (AKI), creatinine is rising and the formula significantly overestimates true GFR. In AKI, clinical judgement, urine output, and trend are more important than any formula.
2. Inaccurate at extremes of muscle mass
Patients with very low muscle mass (elderly, cachectic, amputees) have low creatinine production — their serum creatinine appears falsely low, which overestimates CrCl. Conversely, bodybuilders have high creatinine from high muscle mass, underestimating true GFR.
3. Pregnancy
GFR increases by 40–65% in pregnancy. Standard Cockcroft-Gault underestimates true GFR in pregnant patients — use specialist guidance for drug dosing in this group.
4. Oedematous patients
In patients with significant oedema or ascites, actual body weight includes fluid, which inflates the CrCl estimate. Use estimated dry weight or IBW in these patients.
A Note for Patients
If your doctor has mentioned your “kidney function” or “creatinine level,” here is what it means in plain language.
Creatinine is a waste product your muscles produce constantly. Your kidneys filter it out of your blood and pass it in urine. If your kidneys are not working well, creatinine builds up in the blood — and the blood level rises.
Doctors use a formula (the Cockcroft-Gault equation) to estimate how well your kidneys are filtering, using your creatinine level along with your age, weight, and sex. This gives a number in mL/min — the higher the number, the better the kidneys are working.
- Above 60 mL/min: Kidneys working reasonably well. May need monitoring.
- 30–60 mL/min: Moderate reduction. Some medicines may need dose adjustments. Regular monitoring is important.
- Below 30 mL/min: Significant impairment. Specialist review is usually needed. Many medicines require dose changes or should be avoided.
- Below 15 mL/min: Kidney failure. Discussion about dialysis or transplant may begin.
Reduced kidney function does not always cause symptoms — which is why blood tests are so important for detecting it early.
Summary
- Creatinine clearance (CrCl) estimates GFR using the Cockcroft-Gault formula: [(140 − Age) × Weight × F] ÷ Serum Creatinine
- F = 1.23 for males, 1.04 for females. Creatinine in µmol/L, weight in kg, age in years
- Use CrCl (not lab eGFR) for drug dosing — most pharmacokinetic trial data is based on Cockcroft-Gault
- Use ideal body weight in obese patients (BMI >30) to avoid overestimating CrCl
- A normal-looking creatinine in an elderly, thin patient can hide severe renal impairment — always calculate
- Cockcroft-Gault is not valid in AKI, pregnancy, extremes of muscle mass, or significant oedema
- Key drugs requiring renal dose adjustment: metformin, LMWH, digoxin, gentamicin, DOACs, trimethoprim, NSAIDs
- Always cross-check doses with current BNF and local formulary
References
- Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron. 1976;16(1):31–41.
- KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int Suppl. 2013;3(1):1–150.
- NICE. Chronic kidney disease in adults: assessment and management. Guideline NG203. Updated 2023.
- Joint Formulary Committee. British National Formulary (BNF). London: BMJ Group and Pharmaceutical Press. Current edition.
- Levey AS, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604–612.
- Stevens LA, et al. Assessing kidney function — measured and estimated glomerular filtration rate. N Engl J Med. 2006;354(23):2473–2483.
Explore All AI Medical Tools
MedDraftPro offers free AI-powered clinical calculators and scoring tools — built for doctors, by a doctor. No login required.
Practicing physician and founder of MedDraftPro. Dr. Biswas writes evidence-based clinical guides to help doctors and medical students work faster and more confidently at the bedside.